NATIONAL INSTITUTES OF HEALTH

Bolder BioTechnology, Inc. announces NIAID's funding for BBT-059 development as a radiation medical countermeasure, aiming to complete GMP manufacturing and preclinical safety studies for an Investigational New Drug Application filing. The contract totals $3,079,369, contingent on milestone achievements.

UC Cancer Center receives $2.3M NCI grant to develop a novel technique using PET scans to visualize genetically modified immune cells in cancer patients, aiming to improve CAR T-cell therapy for solid tumors.

NIH developed AI algorithm TrialGPT matches potential volunteers to relevant clinical trials on ClinicalTrials.gov, improving enrollment efficiency and accuracy. TrialGPT processes patient summaries, identifies eligible trials, and explains eligibility criteria, saving clinicians 40% screening time. Selected for Director's Challenge Innovation Award to further assess real-world performance.

NIH developed AI algorithm, TrialGPT, matches potential volunteers to relevant clinical trials on ClinicalTrials.gov, saving clinicians time and accelerating research. TrialGPT processes patient summaries, identifies eligible trials, and explains eligibility criteria, achieving nearly the same accuracy as human clinicians. A pilot study showed clinicians using TrialGPT spent 40% less time screening patients with the same accuracy. The research team received a Director’s Challenge Innovation Award to further assess TrialGPT’s performance and fairness.

WEF identifies 12 cancer breakthroughs, including Novelna's early-stage cancer test, precision oncology, liquid and synthetic biopsies, and early diagnosis of pancreatic cancer.

NIH researchers developed TrialGPT, an AI algorithm that matches patients with clinical trials on ClinicalTrials.gov, reducing clinician screening time by 40% while maintaining accuracy. The tool aims to enhance trial enrollment and medical research advancements, with ongoing evaluation for real-world effectiveness and fairness.

NIH researchers developed TrialGPT, an AI algorithm to match potential volunteers to clinical trials on ClinicalTrials.gov. TrialGPT processes patient summaries to identify and explain eligibility for relevant trials, reducing clinician screening time by 40% while maintaining accuracy. The tool aims to improve clinical trial enrollment and accelerate medical research.

West Texas A&M University’s College of Engineering received a $350,000 NSF grant to enhance industrial and governmental partnerships, focusing on AI, biotechnology, semiconductors, and new materials. The grant aims to improve partnership development processes, establish a training program, and expand the network of external partners, ultimately benefiting students through increased research and internship opportunities.

Researchers at Linköping University identified the exact location of CaV2.2 calcium channels, crucial for pain signal strength, and discovered G-proteins make these channels more 'reluctant' to open, suggesting targeted drug design for effective pain relief with fewer side effects.

Robert F. Kennedy Jr. opposes using medications like Ozempic for obesity and diabetes, advocating for dietary and behavioral changes instead, despite Denmark's use of Ozempic and its sister drug Wegovy. Kennedy's anti-vaccine stance and misleading statements worry public health experts, who argue that medication should not be demonized and that lifestyle changes alone do not solve obesity.